Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 3,185 | 3,040 | 4,378 | 3,860 | 3,771 |
| Gross Profit | 3,185 | 3,040 | 4,378 | 3,860 | 3,771 |
| Operating Expenses | 35,396 | 32,799 | 31,678 | 31,243 | 21,794 |
| Operating Income | -32,211 | -29,759 | -27,300 | -27,383 | -18,023 |
| Interest Expense | 826 | 817 | 883 | 818 | 820 |
| Other Income | 2,639 | 1,991 | 908 | 218 | 58 |
| Pre-tax Income | -30,398 | -28,585 | -27,275 | -27,983 | -18,785 |
| Income Tax | -420 | -238 | -447 | -419 | -748 |
| Net Income Continuous | -29,978 | -28,347 | -26,828 | -27,564 | -18,037 |
| Net Income | $-29,978 | $-28,347 | $-26,828 | $-27,564 | $-18,037 |
| EPS Basic Total Ops | -1.01 | -0.96 | -0.90 | -0.93 | -0.61 |
| EPS Basic Continuous Ops | -1.01 | -0.96 | -0.90 | -0.93 | -0.60 |
| EPS Diluted Total Ops | -1.01 | -0.96 | -0.90 | -0.93 | -0.61 |
| EPS Diluted Continuous Ops | -1.01 | -0.96 | -0.90 | -0.93 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -0.96 | -0.90 | N/A | N/A |
| EBITDA(a) | $-30,825 | $-28,495 | $-26,683 | $-26,961 | $-17,616 |